Abiomed, Inc.ABMDNASDAQ

Revenue (LTM)

$1.0B

+21.7% YoY

Net Income (LTM)

$137M

-39.5% YoY

Free Cash Flow

$250M

Revenue CAGR (5Y)

+18.3%

—Marginsstable

FCF$0.2B

Profitable

Metric	Mar 18	Mar 19	Mar 20	Mar 21	Mar 22
Revenue	594	769↑29.6%	841↑9.3%	848↑0.8%	1,032↑21.7%
Gross Profit	495	640↑29.2%	690↑7.8%	686↓0.6%	844↑23.0%
Operating Income	157	225↑43.1%	249↑10.9%	230↓7.9%	373↑62.4%
Net Income	112	259↑130.9%	203↓21.6%	226↑11.1%	137↓39.5%
EBITDA	164	231↑40.3%	257↑11.6%	247↓4.1%	500↑102.7%
EPS Diluted	2.45	5.61↑129.0%	4.43↓21.0%	4.94↑11.5%	2.98↓39.7%

Metric	Mar 18	Mar 19	Mar 20	Mar 21	Mar 22
Cash & Equivalents	43	121↑181.6%	192↑58.9%	233↑21.0%	133↓42.9%
Total Current Assets	494	677↑37.0%	636↓6.1%	788↑23.9%	976↑23.9%
Total Assets	786	1,054↑34.1%	1,216↑15.4%	1,494↑22.8%	1,673↑12.0%
Total Current Liabilities	85	106↑25.2%	132↑24.4%	129↓2.2%	138↑7.4%
Total Liabilities	97	117↑21.3%	151↑28.6%	165↑9.1%	170↑3.3%
Total Equity	690	937↑35.9%	1,065↑13.7%	1,330↑24.8%	1,503↑13.1%
Total Debt	0	0	0	0	0
Net Debt	-43	-121↓181.6%	-192↓58.9%	-233↓21.0%	-133↑42.9%

Metric	Mar 18	Mar 19	Mar 20	Mar 21	Mar 22
Operating Cash Flow	193	252↑31.0%	315↑24.9%	275↓12.8%	285↑3.9%
Capital Expenditure	-56	-44↑21.2%	-44↓0.0%	-53↓21.3%	-36↑33.0%
Free Cash Flow	137	208↑52.3%	271↑30.1%	221↓18.4%	250↑12.9%
Stock-Based Comp	40	0	40	47↑18.2%	53↑12.2%
Net Change in Cash	4	78↑1883.4%	71↓8.6%	40↓43.4%	-100↓347.4%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance